KRISTINA DAHLSTROM to Female
This is a "connection" page, showing publications KRISTINA DAHLSTROM has written about Female.
Connection Strength
0.439
-
Prevention and Screening of HPV Malignancies. Semin Radiat Oncol. 2021 10; 31(4):297-308.
Score: 0.030
-
Conditional survival among patients with oropharyngeal cancer treated with radiation therapy and alive without recurrence 5 years after diagnosis. Cancer. 2021 04 15; 127(8):1228-1237.
Score: 0.028
-
Medical Care Costs Associated with Genital Warts for Commercially Insured US Patients. Pharmacoeconomics. 2018 11; 36(11):1355-1365.
Score: 0.024
-
The epidemiology of oral human papillomavirus infection in healthy populations: A systematic review and meta-analysis. Oral Oncol. 2018 07; 82:91-99.
Score: 0.024
-
Diagnostic accuracy of serum antibodies to human papillomavirus type 16 early antigens in the detection of human papillomavirus-related oropharyngeal cancer. Cancer. 2017 Dec 15; 123(24):4886-4894.
Score: 0.023
-
Proposed Staging System for Patients With HPV-Related Oropharyngeal Cancer Based on Nasopharyngeal Cancer N Categories. J Clin Oncol. 2016 06 01; 34(16):1848-54.
Score: 0.020
-
Socioeconomic characteristics of patients with oropharyngeal carcinoma according to tumor HPV status, patient smoking status, and sexual behavior. Oral Oncol. 2015 Sep; 51(9):832-8.
Score: 0.019
-
Circulating human papillomavirus DNA as a marker for disease extent and recurrence among patients with oropharyngeal cancer. Cancer. 2015 Oct 01; 121(19):3455-64.
Score: 0.019
-
HPV Serum Antibodies as Predictors of Survival and Disease Progression in Patients with HPV-Positive Squamous Cell Carcinoma of the Oropharynx. Clin Cancer Res. 2015 Jun 15; 21(12):2861-9.
Score: 0.019
-
An evolution in demographics, treatment, and outcomes of oropharyngeal cancer at a major cancer center: a staging system in need of repair. Cancer. 2013 Jan 01; 119(1):81-9.
Score: 0.016
-
Differences in history of sexual behavior between patients with oropharyngeal squamous cell carcinoma and patients with squamous cell carcinoma at other head and neck sites. Head Neck. 2011 Jun; 33(6):847-55.
Score: 0.014
-
Squamous cell carcinoma of the head and neck in never smoker-never drinkers: a descriptive epidemiologic study. Head Neck. 2008 Jan; 30(1):75-84.
Score: 0.012
-
Impact of pretreatment body mass index on the survival of head and neck cancer patients. Head Neck. 2024 08; 46(8):1881-1892.
Score: 0.009
-
Human papillomavirus type 16 infection and squamous cell carcinoma of the head and neck in never-smokers: a matched pair analysis. Clin Cancer Res. 2003 Jul; 9(7):2620-6.
Score: 0.008
-
Stepped Behavioral and Biological Screening for Oral Oncogenic HPV DNA in Middle-aged and Elderly Adults: A Feasibility Study. Cancer Prev Res (Phila). 2023 03 01; 16(3):127-132.
Score: 0.008
-
A synthesis of evidence for cancer-specific screening interventions: A Preventive Medicine Golden Jubilee Review. Prev Med. 2023 02; 167:107395.
Score: 0.008
-
A Cross-Sectional Study of the Prevalence of Anal Dysplasia among Women with High-Grade Cervical, Vaginal, and Vulvar Dysplasia or Cancer: The PANDA Study. Cancer Epidemiol Biomarkers Prev. 2022 12 05; 31(12):2185-2191.
Score: 0.008
-
An economic and disease transmission model of human papillomavirus and oropharyngeal cancer in Texas. Sci Rep. 2021 01 19; 11(1):1802.
Score: 0.007
-
Blood-based biomarkers of human papillomavirus-associated cancers: A systematic review and meta-analysis. Cancer. 2021 03 15; 127(6):850-864.
Score: 0.007
-
A Genome-Wide Association Study Identifies Two Novel Susceptible Regions for Squamous Cell Carcinoma of the Head and Neck. Cancer Res. 2020 06 15; 80(12):2451-2460.
Score: 0.007
-
Prognostic implications of human papillomavirus status and p16 expression in laryngeal squamous cell carcinoma. Head Neck. 2019 12; 41(12):4151-4163.
Score: 0.006
-
Direct medical cost of oropharyngeal cancer among patients insured by Medicaid in Texas. Oral Oncol. 2019 09; 96:21-26.
Score: 0.006
-
Cost of treating recurrent respiratory papillomavirus in commercially insured and medicaid patients. Laryngoscope. 2020 05; 130(5):1186-1194.
Score: 0.006
-
Projected oropharyngeal carcinoma incidence among middle-aged US men. Head Neck. 2019 09; 41(9):3226-3234.
Score: 0.006
-
Prevalence of high-grade anal dysplasia among women with high-grade lower genital tract dysplasia or cancer: Results of a pilot study. Gynecol Oncol. 2019 05; 153(2):266-270.
Score: 0.006
-
Age-Structured Population Modeling of HPV-related Cervical Cancer in Texas and US. Sci Rep. 2018 09 25; 8(1):14346.
Score: 0.006
-
A TGF-?1 genetic variant at the miRNA187 binding site significantly modifies risk of HPV16-associated oropharyngeal cancer. Int J Cancer. 2018 09 15; 143(6):1327-1334.
Score: 0.006
-
Medical Care Cost of Oropharyngeal Cancer among Texas Patients. Cancer Epidemiol Biomarkers Prev. 2017 09; 26(9):1443-1449.
Score: 0.006
-
Apoptotic capacity and risk of squamous cell carcinoma of the head and neck. Eur J Cancer. 2017 02; 72:166-176.
Score: 0.005
-
Human papillomavirus integration pattern and demographic, clinical, and survival characteristics of patients with oropharyngeal squamous cell carcinoma. Head Neck. 2016 08; 38(8):1139-44.
Score: 0.005
-
Squamous cell carcinoma of the oral cavity often overexpresses p16 but is rarely driven by human papillomavirus. Oral Oncol. 2016 May; 56:47-53.
Score: 0.005
-
Reduced DNA double-strand break repair capacity and risk of squamous cell carcinoma of the head and neck--A case-control study. DNA Repair (Amst). 2016 Apr; 40:18-26.
Score: 0.005
-
Development and validation of a staging system for HPV-related oropharyngeal cancer by the International Collaboration on Oropharyngeal cancer Network for Staging (ICON-S): a multicentre cohort study. Lancet Oncol. 2016 04; 17(4):440-451.
Score: 0.005
-
A variant at a potentially functional microRNA-binding site in BRIP1 was associated with risk of squamous cell carcinoma of the head and neck. Tumour Biol. 2016 Jun; 37(6):8057-66.
Score: 0.005
-
HPV16 antibodies as risk factors for oropharyngeal cancer and their association with tumor HPV and smoking status. Oral Oncol. 2015 Jul; 51(7):662-7.
Score: 0.005
-
Metabolic activity measured on PET/CT correlates with clinical outcomes in patients with limb and girdle sarcomas. J Surg Oncol. 2014 Apr; 109(5):410-4.
Score: 0.004
-
Telomere length in peripheral blood lymphocytes contributes to the development of HPV-associated oropharyngeal carcinoma. Cancer Res. 2013 Oct 01; 73(19):5996-6003.
Score: 0.004
-
Comparison of the accuracy of Hybrid Capture II and polymerase chain reaction in detecting clinically important cervical dysplasia: a systematic review and meta-analysis. Cancer Med. 2013 Jun; 2(3):367-90.
Score: 0.004
-
Incidence and pattern of second primary malignancies in patients with index oropharyngeal cancers versus index nonoropharyngeal head and neck cancers. Cancer. 2013 Jul 15; 119(14):2593-601.
Score: 0.004
-
Low risk of second primary malignancies among never smokers with human papillomavirus-associated index oropharyngeal cancers. Head Neck. 2013 Jun; 35(6):794-9.
Score: 0.004
-
Human papillomavirus seropositivity synergizes with MDM2 variants to increase the risk of oral squamous cell carcinoma. Cancer Res. 2010 Sep 15; 70(18):7199-208.
Score: 0.003
-
Association of TGF-beta1 genetic variants with HPV16-positive oropharyngeal cancer. Clin Cancer Res. 2010 Mar 01; 16(5):1416-22.
Score: 0.003
-
p53 codon 72 polymorphism associated with risk of human papillomavirus-associated squamous cell carcinoma of the oropharynx in never-smokers. Carcinogenesis. 2008 Apr; 29(4):875-9.
Score: 0.003
-
Serum cotinine concentration and wound complications in head and neck reconstruction. Plast Reconstr Surg. 2008 Feb; 121(2):451-457.
Score: 0.003
-
A pilot study of Helicobacter pylori infection and risk of laryngopharyngeal cancer. Head Neck. 2005 Jan; 27(1):22-7.
Score: 0.002
-
Gamma radiation-induced apoptosis, G2 delay, and the risk of salivary and thyroid carcinomas--a preliminary report. Head Neck. 2004 Jul; 26(7):612-8.
Score: 0.002
-
DNA repair gene ERCC1 and ERCC2/XPD polymorphisms and risk of squamous cell carcinoma of the head and neck. Arch Otolaryngol Head Neck Surg. 2002 Sep; 128(9):1084-8.
Score: 0.002
-
A variant of the DNA repair gene XRCC3 and risk of squamous cell carcinoma of the head and neck: a case-control analysis. Int J Cancer. 2002 Jun 20; 99(6):869-72.
Score: 0.002
-
Alcohol dehydrogenase 3 genotype is not associated with risk of squamous cell carcinoma of the oral cavity and pharynx. Cancer Epidemiol Biomarkers Prev. 2001 Mar; 10(3):273-5.
Score: 0.002